A new RCT suggests that following a six-week period of bovine colostrum supplementation, the frequency and gravity of upper respiratory tract infection (URTI) symptoms significantly reduced in pre-school aged children.
Colostrum BioTec GmbH says more should be done to educate consumers about the virtues of bovine colostrum, the nutrient-rich fluid that’s making waves in the nutraceutical industry.
A new trial concludes that bovine colostrum (COL) can reduce risk of upper respiratory tract infections (URTIs) in non-athletic adults at heightened risk of infection, adding to a body of research previously concentrating on athletes.
Maolac no longer wants to be thought of as ‘the colostrum company’, but a biotech championing biofunctional proteins from both animal and non-animal sources, CEO Maya Ashkenazi explains.
The global bovine colostrum market will expand at about 6.4% CAGR over the next six years to gain revenues of around €3.6bn ($4.3 bn) by the end of 2027, according to analysts from Transparency Market Research (TMR).
